These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17418370)

  • 1. Glycogen synthase kinase-3beta -- actively inhibiting hypertrophy.
    Kerkelä R; Woulfe K; Force T
    Trends Cardiovasc Med; 2007 Apr; 17(3):91-6. PubMed ID: 17418370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway.
    Chen K; Rekep M; Wei W; Wu Q; Xue Q; Li S; Tian J; Yi Q; Zhang G; Zhang G; Xiao Q; Luo J; Liu Y
    Cardiovasc Drugs Ther; 2018 Feb; 32(1):5-21. PubMed ID: 29435775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload.
    Tateishi A; Matsushita M; Asai T; Masuda Z; Kuriyama M; Kanki K; Ishino K; Kawada M; Sano S; Matsui H
    Gen Thorac Cardiovasc Surg; 2010 Jun; 58(6):265-70. PubMed ID: 20549454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.
    Barillas R; Friehs I; Cao-Danh H; Martinez JF; del Nido PJ
    Ann Thorac Surg; 2007 Jul; 84(1):126-33. PubMed ID: 17588398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
    Hardt SE; Tomita H; Katus HA; Sadoshima J
    Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload.
    Yamamoto F; Yamamoto H
    Gen Thorac Cardiovasc Surg; 2010 Jun; 58(6):263-4. PubMed ID: 20549453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
    Palfi A; Toth A; Hanto K; Deres P; Szabados E; Szereday Z; Kulcsar G; Kalai T; Hideg K; Gallyas F; Sumegi B; Toth K; Halmosi R
    J Mol Cell Cardiol; 2006 Jul; 41(1):149-59. PubMed ID: 16716347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy.
    van de Schans VA; van den Borne SW; Strzelecka AE; Janssen BJ; van der Velden JL; Langen RC; Wynshaw-Boris A; Smits JF; Blankesteijn WM
    Hypertension; 2007 Mar; 49(3):473-80. PubMed ID: 17210832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinases 3alpha and 3beta in cardiac myocytes: regulation and consequences of their inhibition.
    Markou T; Cullingford TE; Giraldo A; Weiss SC; Alsafi A; Fuller SJ; Clerk A; Sugden PH
    Cell Signal; 2008 Jan; 20(1):206-18. PubMed ID: 17993264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of cardiac glucose metabolism in association to low birth weight: experimental evidence in lambs with left ventricular hypertrophy.
    Wang KC; Lim CH; McMillen IC; Duffield JA; Brooks DA; Morrison JL
    Metabolism; 2013 Nov; 62(11):1662-72. PubMed ID: 23928106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins inhibit reoxygenation-induced cardiomyocyte apoptosis: role for glycogen synthase kinase 3beta and transcription factor beta-catenin.
    Bergmann MW; Rechner C; Freund C; Baurand A; El Jamali A; Dietz R
    J Mol Cell Cardiol; 2004 Sep; 37(3):681-90. PubMed ID: 15350841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins.
    Menon B; Johnson JN; Ross RS; Singh M; Singh K
    J Mol Cell Cardiol; 2007 Mar; 42(3):653-61. PubMed ID: 17292911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSK-3beta acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis.
    Lin CF; Chen CL; Chiang CW; Jan MS; Huang WC; Lin YS
    J Cell Sci; 2007 Aug; 120(Pt 16):2935-43. PubMed ID: 17666435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin prevents cardiac remodeling secondary to chronic renal failure through deactivation of hypertrophic signaling in rats.
    Ghosh SS; Salloum FN; Abbate A; Krieg R; Sica DA; Gehr TW; Kukreja RC
    Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H975-84. PubMed ID: 20601462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Wnt/frizzled/GSK-3 beta pathway: a novel therapeutic target for cardiac hypertrophy.
    Blankesteijn WM; van de Schans VA; ter Horst P; Smits JF
    Trends Pharmacol Sci; 2008 Apr; 29(4):175-80. PubMed ID: 18342376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reoxygenation after severe hypoxia induces cardiomyocyte hypertrophy in vitro: activation of CREB downstream of GSK3beta.
    El Jamali A; Freund C; Rechner C; Scheidereit C; Dietz R; Bergmann MW
    FASEB J; 2004 Jul; 18(10):1096-8. PubMed ID: 15155564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of glycogen synthase kinase 3beta during heart failure is protective.
    Hirotani S; Zhai P; Tomita H; Galeotti J; Marquez JP; Gao S; Hong C; Yatani A; Avila J; Sadoshima J
    Circ Res; 2007 Nov; 101(11):1164-74. PubMed ID: 17901358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.
    Koh SH; Noh MY; Kim SH
    Brain Res; 2008 Jan; 1188():254-62. PubMed ID: 18031715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis.
    Farago M; Dominguez I; Landesman-Bollag E; Xu X; Rosner A; Cardiff RD; Seldin DC
    Cancer Res; 2005 Jul; 65(13):5792-801. PubMed ID: 15994955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.